JP2008519001A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008519001A5 JP2008519001A5 JP2007539555A JP2007539555A JP2008519001A5 JP 2008519001 A5 JP2008519001 A5 JP 2008519001A5 JP 2007539555 A JP2007539555 A JP 2007539555A JP 2007539555 A JP2007539555 A JP 2007539555A JP 2008519001 A5 JP2008519001 A5 JP 2008519001A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- formula
- alkenyl
- cooh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 8
- 125000005843 halogen group Chemical group 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 125000000304 alkynyl group Chemical group 0.000 claims 6
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 3
- -1 —NH 2 Chemical group 0.000 claims 3
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 2
- 102100037357 Thymidylate kinase Human genes 0.000 claims 2
- 101710102179 Thymidylate kinase Proteins 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 206010024229 Leprosy Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000003106 haloaryl group Chemical group 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 229940113082 thymine Drugs 0.000 claims 1
- 229940035893 uracil Drugs 0.000 claims 1
- 0 *CCCc1ccc(CN(C=C(C(N2)=O)Br)C2=O)cc1 Chemical compound *CCCc1ccc(CN(C=C(C(N2)=O)Br)C2=O)cc1 0.000 description 7
- PCEMNJLLHJFLAF-UHFFFAOYSA-N CC(C(N1)=O)=CN(Cc(cc2)ccc2Br)C1=O Chemical compound CC(C(N1)=O)=CN(Cc(cc2)ccc2Br)C1=O PCEMNJLLHJFLAF-UHFFFAOYSA-N 0.000 description 1
- JAEFDWNQYNAJNM-UHFFFAOYSA-N CC(C(N1)=O)=CN(Cc2ccc(CCCCCC(O)=O)cc2)C1=O Chemical compound CC(C(N1)=O)=CN(Cc2ccc(CCCCCC(O)=O)cc2)C1=O JAEFDWNQYNAJNM-UHFFFAOYSA-N 0.000 description 1
- UVFSHXXKFQMHIJ-UHFFFAOYSA-N OC(CCc1ccc(CN(CC(C(N2)=O)Cl)C2=O)cc1)=O Chemical compound OC(CCc1ccc(CN(CC(C(N2)=O)Cl)C2=O)cc1)=O UVFSHXXKFQMHIJ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04292629A EP1655288A1 (en) | 2004-11-05 | 2004-11-05 | Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| PCT/EP2005/012346 WO2006048336A2 (en) | 2004-11-05 | 2005-11-04 | Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008519001A JP2008519001A (ja) | 2008-06-05 |
| JP2008519001A5 true JP2008519001A5 (enExample) | 2008-12-25 |
Family
ID=34931507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007539555A Withdrawn JP2008519001A (ja) | 2004-11-05 | 2005-11-04 | アリールピリミジル化合物、それらを含む医薬組成物、抗菌剤としてのそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080096907A1 (enExample) |
| EP (2) | EP1655288A1 (enExample) |
| JP (1) | JP2008519001A (enExample) |
| CN (1) | CN101098860A (enExample) |
| BR (1) | BRPI0517646A (enExample) |
| CA (1) | CA2586073A1 (enExample) |
| WO (1) | WO2006048336A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI445696B (zh) * | 2010-11-29 | 2014-07-21 | Univ Nat Yang Ming | 標靶人類胸線核苷酸激酶誘導惡性腫瘤中的ｄｎａ修復毒性 |
| RU2475482C1 (ru) * | 2012-01-13 | 2013-02-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Башкирский государственный университет" | Комплексное соединение 5-гидрокси-6-метилурацила с сукцинатом натрия и способ его получения |
| CA3018611C (en) * | 2016-03-22 | 2024-02-27 | Glaxosmithkline Intellectual Property Development Limited | Antituberculosis agent |
| US20220041627A1 (en) * | 2018-12-04 | 2022-02-10 | University Of Maryland, Baltimore | Prodrugs of anti-cancer and anti-autoimmune diseases therapeutic agents, and methods of making and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1959705A1 (de) * | 1969-11-28 | 1971-06-03 | Bayer Ag | Verfahren zur Herstellung von Uracilderivaten |
| JPH08325238A (ja) * | 1995-05-30 | 1996-12-10 | Asahi Glass Co Ltd | ５−トリフルオロメチルウラシル誘導体およびその製造方法 |
| ATE201016T1 (de) * | 1995-06-09 | 2001-05-15 | Hoffmann La Roche | Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten |
| EP1255738B1 (en) * | 2000-01-25 | 2012-03-07 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| JP4542311B2 (ja) * | 2001-01-29 | 2010-09-15 | バイオ−ラッド ラボラトリーズ インコーポレイテッド | 核酸誘導体 |
| US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
-
2004
- 2004-11-05 EP EP04292629A patent/EP1655288A1/en not_active Withdrawn
-
2005
- 2005-11-04 JP JP2007539555A patent/JP2008519001A/ja not_active Withdrawn
- 2005-11-04 WO PCT/EP2005/012346 patent/WO2006048336A2/en not_active Ceased
- 2005-11-04 CA CA002586073A patent/CA2586073A1/en not_active Abandoned
- 2005-11-04 US US11/718,764 patent/US20080096907A1/en not_active Abandoned
- 2005-11-04 BR BRPI0517646-8A patent/BRPI0517646A/pt not_active IP Right Cessation
- 2005-11-04 EP EP05819227A patent/EP1814867A2/en not_active Withdrawn
- 2005-11-04 CN CNA2005800460269A patent/CN101098860A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004516314A5 (enExample) | ||
| JP2002513793A5 (enExample) | ||
| JP2004518723A5 (enExample) | ||
| JPH10279578A5 (enExample) | ||
| UY26512A1 (es) | Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| RU2003120080A (ru) | Орто-замещенные азотсодержащие бисарильные соединения для применения в качестве ингибиторов калиевого канала, а также содержащие их фармацевтические композиции | |
| JP2005508962A5 (enExample) | ||
| JP2004500426A5 (enExample) | ||
| KR101360556B9 (ko) | 글리코피롤레이트 및 베타2 아드레날린 수용체아고니스트의 조합물 | |
| JP2010501478A5 (enExample) | ||
| JP2002538142A5 (enExample) | ||
| JP2005536503A5 (enExample) | ||
| JP2002527414A5 (enExample) | ||
| JP2007500222A5 (enExample) | ||
| KR960704876A (ko) | 혈소판 응집 저해 작용을 갖는 신규 화합물 (Novel Compound Having Platelet Aggregation Inhibitor Effect) | |
| JP2005512965A5 (enExample) | ||
| JP2004532828A5 (enExample) | ||
| CA2626451A1 (en) | Cyclopropylacetic acid derivatives and use thereof | |
| JP2005537262A5 (ja) | 皮膚疾患を局所的に治療するための医薬品 | |
| JP2004521150A5 (enExample) | ||
| UA81640C2 (ru) | Противомикобактериальные соединения, способ их получения, фармацевтическая композиция на их основе | |
| JP2008519001A5 (enExample) | ||
| JPH1036365A5 (enExample) | ||
| JP2001518468A5 (enExample) | ||
| KR970703301A (ko) | 신규 디아미노메틸리덴 유도체(novel diamincmethylidene derivative) |